FGF21 and Obesity: The thermogenic functions in the iWAT and BAT of mice treated with pemafibrate were increased via increased hepatic FGF21 production and the direct effects of pemafibrate on PPARα in peripheral tissues, leading to the amelioration of obesity-induced dysfunction.